EDGAR Filing Documents for 0001479290-19-000109

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001479290-19-000109

Filing Date

2019-11-04

Accepted

2019-11-04 16:14:07

Documents

Period of Report

2019-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	rvncq31910q.htm iXBRL	10-Q	1532498
2	EXHIBIT 10.1	ex101q31910qmylan.htm	EX-10.1	35164
3	EXHIBIT 10.2	ex102q31910qseparation.htm	EX-10.2	52230
4	EXHIBIT 10.3	ex103q31910qseverancep.htm	EX-10.3	135437
5	EXHIBIT 10.4	ex104q31910qmarkfoley.htm	EX-10.4	44402
6	EXHIBIT 10.5	ex105q319nonemployeedi.htm	EX-10.5	20750
7	EXHIBIT 31.1	rvnc-q319exhibit311.htm	EX-31.1	13013
8	EXHIBIT 31.2	rvnc-q319exhibit312.htm	EX-31.2	12883
9	EXHIBIT 32.1	rvnc-q319exhibit321.htm	EX-32.1	7672
10	EXHIBIT 32.2	rvnc-q319exhibit322.htm	EX-32.2	7672
	Complete submission text file	0001479290-19-000109.txt		5952855

Data Files

Seq	Description	Document	Type	Size
11	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	rvnc-20190930.xsd	EX-101.SCH	36854
12	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	rvnc-20190930_cal.xml	EX-101.CAL	64347
13	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	rvnc-20190930_def.xml	EX-101.DEF	167475
14	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	rvnc-20190930_lab.xml	EX-101.LAB	526468
15	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	rvnc-20190930_pre.xml	EX-101.PRE	288594
53	EXTRACTED XBRL INSTANCE DOCUMENT	rvncq31910q_htm.xml	XML	805425

Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560

Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400

Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)